my private podcast channel
Stormy Daniels testifies. Former President Trump's classified documents trial delayed. Israel seizes Gaza’s Rafah crossing. CBS News Correspondent Jennifer Keiper with tonight's World News Roundup.
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
The Wolves Of K Street: The Secret History of How Big Money Took Over Big Government is a new book detailing how the influence business took root and metastasized in federal politics. Co-author and Wall Street Journal Pulitzer Prize-winning reporter Brody Mullins discusses. Plus, President Biden decries anti-semitism as he stands by Israel as it begins the Rafah phase of the war. And we hear from Nibbles, an overlooked participant in the Kristi Noem quadruped killing spree.
https://surfshark.deals/GIST
Produced by Joel Patterson and Corey Wara
Email us at thegist@mikepesca.com
To advertise on the show, visit: https://advertisecast.com/TheGist
Subscribe to The Gist Subscribe: https://subscribe.mikepesca.com/
Follow Mikes Substack at: Pesca Profundities | MikePesca | Substack
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Kim Wehle joins the show to talk with Ravi about the latest in the Trump case in New York, including why Hope Hicks is such an integral part of the prosecution’s case and how her recent testimony could inform the eventual verdict. They then discuss the presidential pardon power, whether self-pardons are constitutional, and how Trump may attempt to pardon himself regardless of the outcome of the 2024 election.
Ravi and Kim also discuss the controversial prosecution in the Crumbley case, the dynamics of the trial, and what the verdict means for future gun control legislation in the United States.
Kim is a professor at the University of Baltimore School of Law, a legal contributor for ABC News, author of How to Think Like a Lawyer – and Why, and founder of the Simple Politics Substack blog.
Leave us a voicemail with your thoughts on the show! 321-200-0570
Subscribe to our feed on Spotify: http://bitly.ws/zC9K
Subscribe to our Substack: https://thelostdebate.substack.com/
Follow The Branch on Instagram: https://www.instagram.com/thebranchmedia/
Follow The Branch on TikTok: https://www.tiktok.com/@thebranchmedia
Follow The Branch on Twitter: https://twitter.com/thebranchmedia
The Branch website: http://thebranchmedia.org/
Lost Debate is also available on the following platforms:
Apple: https://podcasts.apple.com/us/podcast/the-lost-debate/id1591300785
Google: https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vTERJNTc1ODE3Mzk3Nw
iHeart: https://www.iheart.com/podcast/269-the-lost-debate-88330217/
Amazon Music: https://music.amazon.co.uk/podcasts/752ca262-2801-466d-9654-2024de72bd1f/the-lost-debate
By Joyelle McSweeney
Learn more about your ad choices. Visit megaphone.fm/adchoices
Death and destruction as tornadoes tear through Oklahoma. Israel rejects cease fire plan. American soldier held in Russia. CBS News Correspondent Steve Kathan has today's World News Roundup.
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
There’s a new $6 billion-dollar industry. Its global market size is expected to increase to $100 billion within the decade. No, it’s not a fancy new app or a revolutionary gadget: it’s weight-loss drugs.
Just a few years ago no one had even heard the word Ozempic. Almost overnight, the drug previously used to treat type 2 diabetes became a household name. Healthcare providers wrote more than 9 million prescriptions for Ozempic and similar drugs in the last three months of 2022 alone. By the end of the decade, 30 million people are predicted to be on it. For comparison, that means that Ozempic is on track to do as well as birth control pills and Prozac—a blockbuster medication.
A little over a year ago we had a fiery debate on Honestly about these revolutionary weight-loss drugs and our cultural understanding of obesity. On one side of the debate, people saw Ozempic as the golden answer we’ve been searching for. After all, obesity is the second biggest cause of cancer. It causes diabetes, and it’s linked to dementia, heart disease, knee and hip problems, arthritis, and high blood pressure, which causes strokes. In short: when you crunch the numbers, drugs like Ozempic seem to be lifesaving.
On the other hand was another argument: Why are we putting millions of people on a powerful new drug when we don’t know the risks? Plus, isn’t this a solution that ignores why we gained so much weight in the first place? In other words: Ozempic is not a cure for obesity; it’s a Band-Aid.
A year later, all of those questions are still up for debate. Our guest today, journalist Johann Hari, has spent the last year trying to find answers, traveling the world investigating weight-loss drugs, and. . . taking them himself.
In his latest book, Magic Pill: The Extraordinary Benefits and Disturbing Risks of the New Weight-Loss Drugs, Johann investigates what we know and what we don’t know about how these drugs work, their risks and benefits, how our food system sets us up to fail, and how movements like “fat pride” and “healthy at any size” have completely altered the conversation.
So on today’s episode: How do these new drugs impact our brains, our guts, and our mood? What are the hidden risks? Are they really a permanent solution to the obesity crisis? Or are they merely a quick fix that do little to address the root causes of obesity? With over 70 percent of Americans today classified as overweight or obese and the average American adult weighing nearly 25 pounds more today than they did in 1960, how did we get here in the first place? And why aren’t we addressing that problem, too?
Learn more about your ad choices. Visit megaphone.fm/adchoices